Farmasol has a long and deep experience in production of Concentrate Solutions for Haemodialysis. The Company keeps a close cooperation with its customers aimed at continuous products innovation and implementation of primary containers and closure systems. The co-operation begins in the product formulation phase and continues in the product pre-industrialization and industrialization, including the production of pilot batches, stability studies for registrations, production of batches for clinical trials, ongoing stability, validation of production process and analytical methods. Thanks to the qualified Services offered, to the high technology and flexibility of production process and to the high qualitative standards, the Company signed relevant commercial agreements with the main players in the field of Haemodialysis Therapies.
The production lines have a capacity of 20 million litres per year of concentrate solutions for haemodialysis.
The products can be dispensed in a wide range of primary containers: rigid or flexible, in PVC or PVC free, with a volume from 1 up to 5,4 litres, with many different closure system like breakable konus, vials, injection point.
The production cover all formulations contemplate by European Pharmacopeia including those without acetate and those with citrate.
The company is running a project for the development of a new primary container called “SBS ONE” realized with a monolayer polyolefin of new generation. The industrialization of this new container is foreseen by the end of 2016.